Early behavioral screening for antidepressants and anxiolytics-

Authors
V. Castagné, R. D. Porsolt, P. Moser.


Lab
Porsolt & Partners Pharmacology, Boulogne-Billancourt, France

Journal
Drug Development Research

Abstract
Early preclinical behavioral testing is an essential stage during the development of substances with potential antidepressant and/or anxiolytic activity. With the growing cost of drug development, optimal research strategies are needed to detect potential new treatments with high efficacy and minimal side effects and to confirm in vitro pharmacological studies. In the following article, we present simple rodent tests used for early behavioral testing for antidepressant-like and anxiolytic-like activity. Unpublished results from our laboratory are discussed with reference to published data to illustrate the predictive validity of several behavioral screening tests.

BIOSEB Instruments Used:
Tail Suspension Test - Wireless (BIO-TST5)

Publication request

Merci de votre intérêt pour notre gamme de produits et de votre demande pour cette publication qui vous sera envoyée si l'équipe de recherche et la revue le permettent. Notre équipe commerciale vous contactera dans les plus brefs délais.